140
views
0
recommends
+1 Recommend
1 collections
    1
    shares
      scite_
       
      • Record: found
      • Abstract: found
      • Conference Proceedings: found
      Is Open Access

      Data Driven Approaches to Repurposing

      Published
      conference-abstract
      1
      REPO4EU
      RExPO23
      25-26 October 2023
      Indication Discovery, Transcriptomics, Proteomics, Artificial Intelligence
      Bookmark

            Abstract

            AstraZeneca's Indication Discovery team is using cutting-edge technologies to revolutionize the drug discovery process and improve patient outcomes. By generating Omics signatures for their molecules and using AI and Bioinformatic systems to predict novel connections, we are pushing the boundaries of drug discovery and changing the way medicines are delivered to patients. This talk will focus on a background to these systems and examples of how we are using the outputs.

            Content

            Author and article information

            Conference
            REPO4EU
            4 October 2023
            Affiliations
            [1 ] AstraZeneca, Cambridge (UK);
            Article
            10.58647/REXPO.23014
            7c355ff3-1cc1-48ac-bbc1-b6298ddcb7c7
            Authors

            Published under Creative Commons Attribution 4.0 International ( CC BY 4.0). Users are allowed to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material for any purpose, even commercially), as long as the authors and the publisher are explicitly identified and properly acknowledged as the original source.

            RExPO23
            2
            Stockholm, Sweden
            25-26 October 2023
            History
            Product

            REPO4EU

            Categories

            Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
            Pharmacology & Pharmaceutical medicine
            Indication Discovery,Transcriptomics,Proteomics,Artificial Intelligence

            Comments

            Comment on this article